StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Shares available for future grant under equity by Year

Shares available for future grant under equity compensation plans (millions) (M)

Eli Lilly Shares available for future grant under equity: 42.4M in FY2025, down 13.1% from a year earlier. That is the lowest of the 10 years on record here.

Latest, FY2025
42.4
Period ended Dec 31, 2025
Change on a year earlier
-13.1%
48.8 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-12) ↗

Reported in Form 10-K Stock-Based Compensation Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShares available for future grant under equity compensation plans (millions) (M)Year on yearSource
FY2025Dec 31, 202542.4-13.1%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 202448.8-0.6%Form 10-K (filed 2025-02-19) ↗
FY2023Dec 31, 202349.1-1.8%Form 10-K (filed 2024-02-21) ↗
FY2022Dec 31, 202250-1.2%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 202150.6-6.1%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 202053.9-1.3%Form 10-K (filed 2021-02-17) ↗
FY2019Dec 31, 201954.6+2.4%Form 10-K (filed 2020-02-19) ↗
FY2018Dec 31, 201853.3-45.8%Form 10-K (filed 2019-02-19) ↗
FY2017Dec 31, 201798.3-1.3%Form 10-K (filed 2018-02-20) ↗
FY2016Dec 31, 201699.6–Form 10-K (filed 2017-02-21) ↗

Cite this data

StockData. (2026). Eli Lilly Shares available for future grant under equity (M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/sbc-shares-avail

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.